Seminars in Nuclear Medicine
Volume 37, Issue 3 , Pages 206-222 , May 2007

Increased 18F-Fluorodeoxyglucose Uptake in Benign, Nonphysiologic Lesions Found on Whole-Body Positron Emission Tomography/Computed Tomography (PET/CT): Accumulated Data From Four Years of Experience With PET/CT

  • Ur Metser, MD

      Affiliations

    • Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
    • Department of Radiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
    • Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
    • ,
  • Einat Even-Sapir, MD, PhD

      Affiliations

    • Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
    • Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
    • Corresponding Author InformationAddress reprint requests to Einat Even-Sapir, MD, PhD, Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizman Street, Tel-Aviv 64239, Israel.

References 

  1. Engel H, Steinert H, Buck A, et al. Whole-body PET: Physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med. 1996;37:441–446
  2. Hany TF, Gharehpapagh E, Kamel EM, et al. Brown adipose tissue: A factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging. 2002;29:1393–1398
  3. Metser U, Miller E, Lerman H, et al. Benign, non-physiologic lesions with increased 18F-FDG uptake on PET/CT: Characterization and incidence. 2006;Presented at 2006 SNM Meeting, San Diego
  4. Metser U, Golan O, Levine CD, et al. Tumor lesion detection: When is integrated positron emission tomography/computed tomography more accurate than side-by-side interpretation of positron emission tomography and computed tomography?. J Comput Assist Tomogr. 2005;29:554–559
  5. Antoch G, Saoudi N, Kuehl H, et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: Comparison with CT and PET. G. J Clin Oncol. 2004;22:4357–4368
  6. Pelosi E, Messa C, Sironi S, et al. Value of integrated PET/CT for lesion localisation in cancer patients: A comparative study. Eur J Nucl Med Mol Imaging. 2004;31:932–939
  7. Reinartz P, Wieres FJ, Schneider W, et al. Side-by-side reading of PET and CT scans in oncology: Which patients might profit from integrated PET/CT?. Eur J Nucl Med Mol Imaging. 2004;31:1456–1461
  8. Roitt IM, Delves PJ. Lymphocyte activation. In:  Roitt IM editors. Essential Immunology. (ed 10).. Oxford, UK: Blackwell Scientific; 2001;p. 164–176
  9. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972–1980
  10. Gamelli RL, Liu H, He LK, et al. Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice. J Leukoc Biol. 1996;59:639–647
  11. Fukuzumi M, Shinomya H, Shimizu Y, et al. Endotoxin-induced enhancement of glucose influx into murine peritoneal macrophages via Glut1. Infect Immun. 1996;64:108–112
  12. Paik JY, Lee KH, Choe YS, et al. Augmented 18F-FDG uptake in activated monocytes occurs during the priming process and involves tyrosine kinases and protein kinase C. J Nucl Med. 2004;45:124–128
  13. Babior BM. The respiratory burst of phagocytes. J Clin Invest. 1984;73:599–601
  14. Yamada Y, Uchida Y, Tatsumi K, et al. Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis. J Nucl Med. 1998;39:1160–1166
  15. Walter MA, Melzer RA, Schindler C, et al. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging. 2005;32:674–681
  16. Mahfouz T, Miceli MH, Saghafifar F, et al. 18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: A study of 165 infectious episodes. J Clin Oncol. 2005;23:7857–7863
  17. Rice DH. Diseases of the salivary glands-non-neoplastic. In:  Bailey BJ, et al. editor. Head and Neck Surgery-Otolaryngology. (ed 2).. Philadelphia, PA: JB Lippincott; 1933;p. 19–37
  18. Andrade RS, Heron DE, Degirmenci B, et al. Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys. 2006;65:1315–1322
  19. Asad S, Aquino SL, Piyavisetpat N, et al. False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities. AJR Am J Roentgenol. 2004;182:983–989
  20. Wheeler PS, Stitik FP, Hutchins GM, et al. Diagnosis of lipoid pneumonia by computed tomography. JAMA. 1981;245:65–66
  21. Tahon F, Berthezene Y, Hominal S, et al. Exogenous lipoid pneumonia with unusual CT pattern and FDG positron emission tomography scan findings. Eur Radiol. 2002;12:S171–S173
  22. Brauner MW, Grenier P, Mouelhi MM, et al. Pulmonary histiocytosis X: Evaluation with high-resolution CT. Radiology. 1989;172:255–258
  23. Kamel EM, McKee TA, Calcagni ML, et al. Occult lung infarction may induce false interpretation of 18F-FDG PET in primary staging of pulmonary malignancies. Eur J Nucl Med Mol Imaging. 2005;32:641–646
  24. Rossi SE, Erasmus JJ, McAdams HP, et al. Pulmonary drug toxicity: radiologic and pathologic manifestations. RadioGraphics. 2000;20:245–1259
  25. Shin L, Katz DS, Yung E. Hypermetabolism on F-18 FDG PET of multiple pulmonary nodules resulting from bronchiolitis obliterans organizing pneumonia. Clin Nucl Med. 2004;29:654–656
  26. Lee KS, Kullnig P, Hartmanet TE, et al. Cryptogenic organizing pneumonia: CT findings in 43 patients. AJR Am J Roentgenol. 1994;162:543–554
  27. Lynch DA, Travis WD, Muller NL, et al. Idiopathic interstitial pneumonias: CT features. Radiology. 2005;236:10–21
  28. Messner HH, Soo Hoo GW, Khonsary SA, et al. Idiopathic pulmonary fibrosis: Evaluation with positron emission tomography. Respiration. 2006;73:197–202
  29. Hassaballa HA, Cohen ES, Khan AJ, et al. Positron emission tomography demonstrates radiation-induced changes to nonirradiated lungs in lung cancer patients treated with radiation and chemotherapy. Chest. 2005;128:1448–1452
  30. Tatlidil R, Jadvar H, Bading JR, et al. Incidental colonic fluorodeoxyglucose uptake: Correlation with colonoscopic and histopathologic findings. Radiology. 2002;224:783–787
  31. Frick MP, Maile CW, Crass JR, et al. Computed tomography of neutropenic colitis. AJR Am J Roentgenol. 1984;143:763–765
  32. Donnelly LF, Morris CL. Acute graft-versus-host disease in children: Abdominal CT findings. Radiology. 1996;199:265–268
  33. Samuelson J, Von Lichtenberg F. Infectious diseases. In:  Cotran RS,  Kumar V,  Robbins SL editor. Pathologic basis of disease. (ed 5).. Philadelphia: Saunders; 1994;p. 305–377
  34. Mergo PJ, Ros PR. MR imaging of inflammatory disease of the liver. Magn Reson Imaging Clin N Am. 1997;5:367–376
  35. Huang CJ, Pitt HA, Lipsett PA, et al. Pyogenic hepatic abscess. Ann Surg. 1996;223:600–609
  36. Von Lichtenberg F. Infectious diseases. In:  Cotran RS,  Kumar V,  Robbins SL editor. Pathologic basis of disease. (ed 3).. Philadelphia: Saunders; 1984;p. 385–386
  37. Balthazar EJ. Acute pancreatitis: Assessment of severity with clinical and CT evaluation. Radiology. 2002;223:603–613
  38. Metser U, Miller E, Kessler A, et al. Solid splenic masses: evaluation with 18F-FDG PET/CT. J Nucl Med. 2005;46:52–59
  39. Rao PM, Wittenberg J, Lawrason JN. Primary epiploic appendagitis: Evolutionary changes in CT appearance. Radiology. 1997;204:713–717
  40. Horton KM, Lawler LP, Fishman EK. CT findings in sclerosing mesenteritis (panniculitis): Spectrum of disease. Radiographics. 2003;23:1561–1567
  41. Zissin R, Metser U, Hain D, et al. Mesenteric panniculitis in oncologic patients: PET-CT findings. U. Br J Radiol. 2006;79:37–43
  42. Deichen JT, Prante O, Gack M, et al. Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur J Nucl Med Mol Imaging. 2003;30:267–273
  43. Weber WA. Use of PET for monitoring cancer therapy and for predicting outcome. J Nucl Med. 2005;46:983–995
  44. Ak I, Can C. F-18 FDG PET in detecting renal cell carcinoma. Acta Radiol. 2005;46:895–899
  45. Swingle CA, Baumgarten DA, Schuster DM. Xanthogranulomatous pyelonephritis characterized on PET/CT. Clin Nucl Med. 2005;30:728–729
  46. Majd M, Nussbaum Blask AR, Markle BM, et al. Acute pyelonephritis: comparison of diagnosis with 99mTc-DMSA, SPECT, spiral CT, MR imaging, and power Doppler US in an experimental pig model. Radiology. 2001;218:101–108
  47. Hayes WS, Hartman DS, ISesterbenn IA. From the Archives of the AFIP: Xanthogranulomatous pyelonephritis. Radiographics. 1991;11:485–498
  48. Walsh JW. Computed tomography of gynecologic neoplasms. Radiol Clin North Am. 1992;30:817–818
  49. de Winter F, van de Wiele C, Vogelaers D, et al. Fluorine-18 fluorodeoxyglucose-position emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am. 2001;83:651–660
  50. Mahfouz T, Miceli MH, Saghafifar F, et al. 18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: A study of 165 infectious episodes. J Clin Oncol. 2005;23:7857–7863
  51. Schweitzer ME, Morrison WB. MR imaging of the diabetic foot. Radiol Clin North Am. 2004;42:61–71
  52. Keidar Z, Militianu D, Melamed E, et al. The diabetic foot: initial experience with 18F-FDG PET/CT. J Nucl Med. 2005;46:444–449
  53. Harkess JW. Arthroplasty of hip. In:  Canale ST editors. Campbell’s Operative Orthopaedics. (ed 9).. St. Louis: Mosby; 1998;p. 296–456
  54. Stumpe KD, Notzli HP, Zanetti M, et al. FDG PET for differentiation of infection and aseptic loosening in total hip replacements: comparison with conventional radiography and three-phase bone scintigraphy. Radiology. 2004;231:333–341
  55. Delank KS, Schmidt M, Michael JW, et al. The implications of 18F-FDG PET for the diagnosis of endoprosthetic loosening and infection in hip and knee arthroplasty: Results from a prospective, blinded study. BMC Musculoskelet Disord. 2006;7:20
  56. Liu SH, Chang JT, Ng SH, et al. False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient. Br J Radiol. 2004;77:257–260
  57. Wandler E, Kramer EL, Sherman O, et al. Diffuse FDG shoulder uptake on PET is associated with clinical findings of osteoarthritis. AJR Am J Roentgenol. 2005;185:797–803
  58. Wendling D, Blagosklonov O, Streit G, et al. FDG-PET/CT scan of inflammatory spondylodiscitis lesions in ankylosing spondylitis, and short term evolution during anti-tumour necrosis factor treatment. Ann Rheum Dis. 2005;64:1663–1665
  59. Beckers C, Jeukens X, Ribbens C, et al. (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. Eur J Nucl Med Mol Imaging. 2006;33:275–280
  60. Beckers C, Ribbens C, Andre B, et al. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med. 2004;45:956–964
  61. Campanella N, Moraca A, Pergolini M, et al. Paraneoplastic syndromes in 68 cases of resectable non-small cell lung carcinoma: Can they help in early detection?. Med Oncol. 1999;16:129
  62. Herder GJ, Welling A, De Winter GV, et al. Accessory findings on F-18 FDG positron emission tomography in bronchogenic carcinoma. Clin Nucl Med. 2003;28:58–59
  63. Blockmans D, Stroobants S, Maes A, et al. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: Evidence for inflammation of the aortic arch. Am J Med. 2000;108:246–249
  64. Kobayashi Y, Ishii K, Oda K, et al. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med. 2005;46:917–922
  65. Shim SS, Lee KS, Kim BT, et al. Non-small cell lung cancer: Prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology. 2005;236:1011–1019
  66. Reddy MP, Graham MM. FDG positron emission tomographic imaging of thoracic Castleman’s disease. Clin Nucl Med. 2003;28:325–326
  67. Lim R, Wittram C, Ferry JA, et al. FDG PET of Rosai-Dorfman disease of the thymus. AJR Am J Roentgenol. 2004;182:514
  68. De Souza B, Brunetti A, Fulham MJ, et al. Pituitary microadenomas: A PET study. Radiology. 1990;177:39–44
  69. Metser U, Miller E, Lerman H, et al. 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med. 2006;47:32–37
  70. Yasuda S, Fujii H, Nakahara T, et al. 18F-FDG PET detection of colonic adenomas. J Nucl Med. 2001;42:989–992
  71. Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology. 2001;219:774–777
  72. Watanabe H, Shinozaki T, Yanagawa T, et al. Grading of tumors and tumorlike lesions of bone: Evaluation by FDG PET. J Nucl Med. 2000;41:1695–1701
  73. Urban BA, Fishman EK, Goldman SM, et al. CT evaluation of amyloidosis: Spectrum of disease. Radiographics. 1993;13:1295–1308
  74. Fan CM, Fischman AJ, Kwek BH, et al. Lipomatous hypertrophy of the interatrial septum: increased uptake on FDG PET. AJR Am J Roentgenol. 2005;184:339–342
  75. Tsuchiya T, Osanai T, Ishikawa A, et al. Hibernomas show intense accumulation of FDG positron emission tomography. J Comput Assist Tomogr. 2006;30:333–336

PII: S0001-2998(07)00017-7

doi: 10.1053/j.semnuclmed.2007.01.001

Seminars in Nuclear Medicine
Volume 37, Issue 3 , Pages 206-222 , May 2007

Article Tools

* Image Usage & Resolution